Clinical Trial Update: Azilsartan in Chinese Patients With Mild and Moderate Hypertension [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for azilsartan in Chinese patients with mild to moderate hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Azilsartan (azilsartan)

Snippet

Sponsor: Lee's Pharmaceutical Limited | Conditions: Hypertension | Phase 3 | Status: COMPLETED